Home » Newsletters » BioWorld Science

BioWorld Science

April 24, 2009

View Archived Issues

Universita di Bologna patents novel AChE and BChE inhibitors

GlaxoSmithKline presents novel muscarinic M1 receptor agonists

Novel gonadotropin-releasing hormone receptor antagonists claimed by Kissei

Solvay describes cannabinoid CB1 receptor agonists for pain treatment

Novel beta2-adrenoceptor agonists described by Sepracor for the treatment of bronchoconstriction

In vitro and phase I data on silymarin in hepatitis C presented

Travatan and DuoTrav show comparable efficacy in patients with primary open-angle glaucoma

Dual inhibitors of PI3K and mTOR with in vivo antitumor activity reported by Piramed and Genentech

MK-7009 combined with peginterferon, ribavirin in phase IIa study

Combination of filibuvir and peginterferon alfa-2a/ribavirin evaluated in HCV patients

Haptoglobin level a biomarker for gemcitabine-related hematological toxicities

MK-2206: Development through phase I study described

Immutep commences phase I ImmuFact IMP-321 trial in pancreatic cancer

Tranzyme reports positive phase II TZP-101 results in gastroparesis

FDA approves phase II trial for Bryostatin in Alzheimer's disease

Sanaria initiates phase I whole-parasite malaria vaccine trial

Acorda resubmits NDA for Fampridine-SR for improved walking in MS

Revlimid receives positive final appraisal determination for NHS

The caspase inhibitor GS-9450 well tolerated in phase I trial in healthy individuals

Molecular Sensing and VIB enter agreement in Alzheimer's disease research

NovaBay enters into agreement with the Medical University of Innsbruck

European Commission approves Removab for malignant ascites

Addrenex and Sciele report results for second phase III Clonicel study in ADHD

Dr. Reddy's launches Redispar in India for SHPT due to chronic kidney disease

Takeda discontinues TAK-379 development for diabetes

Vion receives an FDA standard review classification for Onrigin NDA

deCODE grants Celera licenses to risk markers for heart attack, stroke and diabetes

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 17, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
European Commission floats multiple fixes for MDR, IVDR
BioWorld MedTech
The European Union’s struggles with regulations for devices and in vitro diagnostics seem virtually endless, but the European Commission floated a series of...
ATNM-400 radioconjugate shows efficacy in resistant breast cancer
BioWorld Science
Although hormone receptor-positive (HR+) breast cancer accounts for over 70% of cases, 20%-30% of patients still experience relapse despite endocrine therapies...